Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Cancer Stem Cell’S Potential Clinical Implications Publisher



Mirzaei A1, 2 ; Madjd Z3, 4 ; Kadijani AA5 ; Alinaghi S5 ; Akbari A6 ; Tavoosidana G1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Bone and Joint Reconstruction Research Center, Shafa Orthopedic Hospital, Iran University of Medical Sciences, Tehran, Iran
  3. 3. Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Molecular Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran
  5. 5. Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  6. 6. Colorectal Research Center, Iran University of Medical Sciences, Tehran, Iran

Source: International Journal of Cancer Management Published:2017


Abstract

Context: To date, CSCs have been identified in a variety of hematopoietic and solid tumors. Applying CSC in clinical implication still depends on future studies to remove complexities including CSC heterogeneity and CSC similarity to normal stem cells. However, several potential clinical applications including therapeutic, diagnostic and prognostic implications have been introduced for cancer stem cells (CSC). In this review, we discuss previously considered and unconsidered potential clinical application of CSCs including how CSCs could be applied for pan-specific cancer screening and therapy. Evidence Acquisition: We will first discuss the previously proposed CSC clinical implications using a brief review of the literature. Subsequently, we will discuss some theoretical potential CSC implications which have not been discussed before including pan-specific cancer screening and therapy, and present confirmatory references for each part of our hypothesis. Results: We hypothetically demonstrated the presence of similar markers in the CSC subset of different tumors and introduced it as a way to simultaneously screen several cancers using one CSC marker. Conclusions: Simultaneous screening of several cancers applying one CSC marker could be regarded as a novel high-value costconscious cancer screening approach which might evolve cancer screening concept. However, this application remains to be explored in the future instigations. © 2017, Iranian Journal of Cancer Prevention.
Other Related Docs
11. Glance Into Cancer Stem Cells, Journal of Kerman University of Medical Sciences (2016)
16. Advantages and Drawbacks of Dexamethasone in Glioblastoma Multiforme, Critical Reviews in Oncology/Hematology (2022)
21. Anti-Apoptotic Effects of Osteopontin Via the Up-Regulation of Akt/Mtor/Β-Catenin Loop in Acute Myeloid Leukemia Cells, International Journal of Hematology-Oncology and Stem Cell Research (2017)
31. Immunopathology and Immunotherapy of Myeloid Leukemia, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)
33. Association of Lgr5 Expression With Gastric Cancer and Helicobacter Pylori Caga Genotype, Journal of Mazandaran University of Medical Sciences (2021)
35. Epigenetic of Retinoic Acid Receptor ß2 Gene in Breast Cancer, Epigenetics Territory and Cancer (2015)
38. Cancer Stem Cells, Stem Cells in Urology (2020)
40. Chemotherapy: A Double-Edged Sword in Cancer Treatment, Cancer Immunology# Immunotherapy (2022)